Literature DB >> 16701753

COPD: a common disease that is preventable and treatable.

Sonia Buist.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16701753      PMCID： PMC6730687          DOI： 10.1016/j.pcrj.2005.12.004

Source DB:  PubMed          Journal:  Prim Care Respir J        ISSN： 1471-4418


× No keyword cloud information.
  3 in total

1.  Patient-centred assessment of COPD in primary care: experience from a cross-sectional study of health-related quality of life in Europe.

Authors:  Paul W Jones; Guy Brusselle; Roberto W Dal Negro; Montse Ferrer; Peter Kardos; Mark L Levy; Thierry Perez; Juan José Soler Cataluña; Thys van der Molen; Lukasz Adamek; Norbert Banik
Journal:  Prim Care Respir J       Date:  2012-09

2.  Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial.

Authors:  Donald P Tashkin; Dennis E Doherty; Edward Kerwin; Carlos E Matiz-Bueno; Barbara Knorr; Tulin Shekar; Sibabrata Banerjee; Heribert Staudinger
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-02-03

3.  Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD.

Authors:  Dennis E Doherty; Donald P Tashkin; Edward Kerwin; Barbara A Knorr; Tulin Shekar; Sibabrata Banerjee; Heribert Staudinger
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-02-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.